Achilles Historical Income Statement
| ACHL Stock | USD 1.01 0.03 2.88% |
Historical analysis of Achilles Therapeutics income statement accounts such as Depreciation And Amortization of 2.8 M, Selling General Administrative of 16.7 M or Total Revenue of 0.0 can show how well Achilles Therapeutics PLC performed in making a profits. Evaluating Achilles Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Achilles Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Achilles Therapeutics PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Achilles Therapeutics PLC is a good buy for the upcoming year.
Achilles |
About Achilles Income Statement Analysis
Achilles Therapeutics PLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Achilles Therapeutics shareholders. The income statement also shows Achilles investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Achilles Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Achilles Therapeutics PLC. It is also known as Achilles Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Achilles Therapeutics PLC income statement and represents the costs associated with goods and services Achilles Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Achilles Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Achilles Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At this time, Achilles Therapeutics' Tax Provision is quite stable compared to the past year. Income Tax Expense is expected to rise to about 515.5 K this year, although the value of Interest Expense is projected to rise to (6.3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 64.2M | 78.4M | 75.3M | 58.4M | Cost Of Revenue | 3.3M | 3.7M | 4.7M | 2.8M |
Achilles Therapeutics income statement Correlations
Click cells to compare fundamentals
Achilles Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Achilles Therapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 215K | 531K | 3.1M | (7.3M) | (6.6M) | (6.3M) | |
| Ebit | (13.8M) | (33.7M) | (64.2M) | (78.4M) | (75.2M) | (71.4M) | |
| Net Income Applicable To Common Shares | (14.0M) | (33.2M) | (61.1M) | (71.2M) | (64.1M) | (60.9M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.59) | Return On Assets (0.27) | Return On Equity (0.44) |
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.